Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes
Clinical trial NCT01862263 · TERMINATED
Trial details
- NCT number
- NCT01862263
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.